Search research articles
Contact Us
Filters
Showing results (31-40 of 94) with videos related to
Page
of 10
Sort By:
ACS Nano
|
February 12, 2009
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue
Wolfgang Eck, Gary Craig, Aruna Sigdel, et al.
Clinical Colorectal Cancer
|
August 17, 2020
Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis
Rona Yaeger, Viktoriya Paroder, David D B Bates, et al.
Surgery
|
November 18, 2011
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis
Sébastien Gaujoux, Laura Tang, David Klimstra, et al.
Annals of Surgical Oncology
|
July 4, 2012
Synchronous resection of primary and liver metastases for neuroendocrine tumors
Sébastien Gaujoux, Mithat Gonen, Laura Tang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 21, 2007
Pancreatic adenocarcinoma: the actual 5-year survivors
Cristina R Ferrone, Murray F Brennan, Mithat Gonen, et al.
Annals of Surgery
|
June 27, 2007
Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome
Andrew P Barbour, Nabil P Rizk, Mithat Gonen, et al.
Annals of Surgical Oncology
|
October 3, 2007
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
John C Mansour, Laura Tang, Manish Shah, et al.
Gastroenterology
|
December 7, 2007
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
Silke Lassmann, Laura Tang, Marinela Capanu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2007
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma
Nabil P Rizk, Ennapadam Venkatraman, Manjit S Bains, et al.
Journal of Surgical Oncology
|
April 5, 2016
Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China
Liang Cao, Luke V Selby, Xiang Hu, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 94) with videos related to
Sort By:
Page
of 10
ACS Nano
|
February 12, 2009
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue
Wolfgang Eck, Gary Craig, Aruna Sigdel, et al.
Clinical Colorectal Cancer
|
August 17, 2020
Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis
Rona Yaeger, Viktoriya Paroder, David D B Bates, et al.
Surgery
|
November 18, 2011
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis
Sébastien Gaujoux, Laura Tang, David Klimstra, et al.
Annals of Surgical Oncology
|
July 4, 2012
Synchronous resection of primary and liver metastases for neuroendocrine tumors
Sébastien Gaujoux, Mithat Gonen, Laura Tang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 21, 2007
Pancreatic adenocarcinoma: the actual 5-year survivors
Cristina R Ferrone, Murray F Brennan, Mithat Gonen, et al.
Annals of Surgery
|
June 27, 2007
Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome
Andrew P Barbour, Nabil P Rizk, Mithat Gonen, et al.
Annals of Surgical Oncology
|
October 3, 2007
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
John C Mansour, Laura Tang, Manish Shah, et al.
Gastroenterology
|
December 7, 2007
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
Silke Lassmann, Laura Tang, Marinela Capanu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2007
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma
Nabil P Rizk, Ennapadam Venkatraman, Manjit S Bains, et al.
Journal of Surgical Oncology
|
April 5, 2016
Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China
Liang Cao, Luke V Selby, Xiang Hu, et al.
Page
of 10